DUBLIN (AP) _ Horizon Pharma Inc. (HZNP) on Wednesday reported a loss of $32.9 million in its first quarter.
On a per-share basis, the Dublin-based company said it had a loss of 19 cents. Earnings, adjusted for non-recurring costs, came to 30 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 10 cents per share.
The drugmaker posted revenue of $280.4 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $236.8 million.
Horizon Pharma expects full-year revenue in the range of $1.26 billion to $1.28 billion.
Horizon Pharma shares have increased 38% since the beginning of the year. The stock has climbed 85% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HZNP at https://www.zacks.com/ap/HZNP